Texas · Nonprofit
THE OSTEOSARCOMA INSTITUTE
THE OSTEOSARCOMA INSTITUTE (Texas) receives grants from 37 organizations whose IRS filings report $5,780,431 to it, the largest being COMMUNITIES FOUNDATION OF TEXAS INC ($3,816,000). 14 of them have funded it in more than one year, and 75% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2024
- $4.2M
- Funders on record
- 37
- Grants received
- $5.8M
- Net assets
- $6.2M
What The Osteosarcoma Institute does
Mission
The mission of The Osteosarcoma Institute is to dramatically increase treatment options and survival rates in osteosarcoma patients through identifying and funding the most promising and breakthrough osteosarcoma clinical trials and science.
As stated on its FY2024 Form 990.
Programs
The Osteosarcoma Institute executed an agreement to fund a translational grant for a total of $500,000 with emory university. $125,000 of this was funded in 2024.
$125,000 spentof which $125,000 as grants6% of program spendingThe Osteosarcoma Institute executed agreements to fund a total of $500,000 for correlative study and translational science grant with the university of california, san francisco. $175,000 of this was funded in 2024.
$175,000 spentof which $175,000 as grants9% of program spendingThe Osteosarcoma Institute executed agreements to fund two grants for a total of $1,300,000 for a clinical trial and correlative study with the dana farber cancer institute. $306,500 of this was funded in 2024.
$306,500 spentof which $306,500 as grants15% of program spendingThe Osteosarcoma Institute executed an agreement to fund a translational research grant for a total of $500,000 with bc cancer. $283,333 of this grant was funded in 2024.
$283,333 spentof which $283,333 as grants14% of program spendingThe Osteosarcoma Institute executed an agreement to fund a translational research grant for a total of $500,000 with european molecular biology laboratory. $125,000 of this grant was funded in 2024.
$125,000 spentof which $125,000 as grants6% of program spendingThe Osteosarcoma Institute executed an agreement to fund a translational research grant for a total of $500,000 with northwestern university. $125,000 of this grant was funded in 2024.
$125,000 spentof which $125,000 as grants6% of program spendingThe Osteosarcoma Institute executed an agreement to fund correlative studies for a total of $220,000 with stanford university. $110,000 of this grant was funded in 2024.
$110,000 spentof which $110,000 as grants5% of program spendingThe Osteosarcoma Institute executed an agreement to fund a translational grant for a total of $401,411 with university of minnesota. $101,411 of this was funded in 2024.
$101,411 spentof which $101,411 as grants5% of program spendingThe Osteosarcoma Institute executed an agreement to fund a translational grant for a total of $500,000 with baylor college of medicine. $125,000 of this was funded in 2024.
$125,000 spentof which $125,000 as grants6% of program spendingThe Osteosarcoma Institute executed an agreement to fund a translational grant for a total of $500,000 with weill medical college of cornell university. $125,000 of this was funded in 2024.
$125,000 spentof which $125,000 as grants6% of program spendingOther program services expenditures not directly allocable to the twelve on-going research grants during the current year including expenditures of $18,821 for the osi connect program. The osi connect program is a free, patient-centered service offered by the osterosarcoma institute that connects individuals affected by osteosarcoma with expert physicians to answer questions about the disease. The negative $100,000 was a return of a grant payment associated with a canceled grant from 2023.
$411,713 spentof which $-100,000 as grants20% of program spending
The 11 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $2,012,957.
The organization over time
Each line starts at 100 in 2018, so what you read is the shape rather than the size: 150 means half as much again as 2018, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $8.3M to $6.7M (−18%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
95% of THE OSTEOSARCOMA INSTITUTE’s revenue is contributions — more reliant on donations than three-quarters of its peers (51% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 7 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Board chair
Mchenry Tichenor Jr
Chair of board of trustees
As listed on its FY2024 Form 990.
Who funds it, year by year
2018 → 2023: the base broadened from 1 funder to 14 funders, grant income rose $20k → $260k.
8 of 37 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 75% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $10.0M from one payer (the payer shares this organization's board, largest Wwww Foundation). These are real filings, and they are not money THE OSTEOSARCOMA INSTITUTE raised.
From the IRS filings of THE OSTEOSARCOMA INSTITUTE’s funders (the co-funder graph). Top 30 of 37 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
THE OSTEOSARCOMA INSTITUTE leans on a few funders — its largest provides 66% of grant income and the top three 77%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
84% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund THE OSTEOSARCOMA INSTITUTE.
Largest funder’s share by year: 2018 100% · 2019 100% · 2020 99% · 2021 50% · 2022 35% · 2023 42% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
60% of THE OSTEOSARCOMA INSTITUTE's funders are still giving 2 years after their first grant; 38% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
75% of THE OSTEOSARCOMA INSTITUTE's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $1.4M that is directly attributable, 52% of it comes from funders outside Texas, across 10 states.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $4.3M arriving through sponsors registered in 8 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
THE OSTEOSARCOMA INSTITUTE runs a healthier operating margin than three-quarters of the 8,126 health nonprofits its size.
this organization peer median middle 50% of peers· 8,126 health nonprofits $1M–$10M, FY2024
Organizations like THE OSTEOSARCOMA INSTITUTE
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Texas
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
75% of spending goes to programs.
Governance
Public support
70%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Screen this organization
A dated, signed PDF of the compliance screen for THE OSTEOSARCOMA INSTITUTE: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds THE OSTEOSARCOMA INSTITUTE?
- THE OSTEOSARCOMA INSTITUTE (Texas) receives grants from 37 organizations whose IRS filings report $5,780,431 to it, the largest being COMMUNITIES FOUNDATION OF TEXAS INC ($3,816,000). 14 of them have funded it in more than one year, and 75% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does THE OSTEOSARCOMA INSTITUTE have?
- IRS filings report 37 organizations giving $5,780,431 in grants to THE OSTEOSARCOMA INSTITUTE, 14 of which have funded it in more than one year.
- Who is the largest funder of THE OSTEOSARCOMA INSTITUTE?
- COMMUNITIES FOUNDATION OF TEXAS INC is the largest funder on record, with $3,816,000 in grants. The full list of funders is on this page.
- How can an organization like THE OSTEOSARCOMA INSTITUTE find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Texas. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2018–2024), and the filings of 37 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing